Results 151 to 160 of about 117,099 (295)

Microbiome and Gastrointestinal Health

open access: yes
Chapter 22 Microbiome and Gastrointestinal Health Fasih Yousaf1*, Muhammad Abdullah1, Muhammad Adil1, Taha Razzaq1, Khadija Tariq1, Amna Yousaf2, Khurram Ashfaq3 1Faculty of Veterinary Science, University of Agriculture, Faisalabad, Pakistan. 2Shaikh Khalifa Bin Zayed Al Nahyan Medical and Dental College, Pakistan. 3Department of Clinical Medicine
Yousaf, Fasih   +6 more
openaire   +1 more source

Review: interactions between microplastics and the gastrointestinal microbiome [PDF]

open access: yes
Plastics are ubiquitous materials in our daily lives, but their inadequate disposal has led to the widespread distribution of their micro- and nanoparticles in various ecosystems.
Julia Eichinger   +3 more
core   +1 more source

Tackling cancer stemness with nanotechnology in the era of precision medicine

open access: yesBMEMat, EarlyView.
Precise customization of nanoparticles (NPs) enables active targeting of cancer stem cells (CSCs), thereby improving drug delivery and therapeutic efficacy. NP‐based probing enhances CSC detection through imaging and liquid biopsy, whereas diverse therapeutic payloads improve therapeutic outcomes.
Shaolei Guo   +9 more
wiley   +1 more source

Controllable engineered probiotic microspheres for treating ulcerative colitis: A cascade enzyme‐catalyzed strategy to restore intestinal redox homeostasis

open access: yesBMEMat, EarlyView.
A dual strategy integrating genetic engineering and physical encapsulation was proposed to enhance the cell viability and antioxidant properties of probiotics. The cascade antioxidant enzymes released from probiotic microspheres restore intestinal redox homeostasis by eliminating intestinal reactive oxygen species for ulcerative colitis treatment ...
Xiaolong Mao   +9 more
wiley   +1 more source

The impact of iron supplementation on the preterm neonatal gut microbiome: A pilot study.

open access: yesPLoS ONE
ObjectiveThe gastrointestinal microbiome in preterm infants exhibits significant influence on optimal outcomes-with dysbiosis shown to substantially increase the risk of the life-threatening necrotizing enterocolitis.
Matthew VanOrmer   +6 more
doaj   +1 more source

Living Microbial Drugs

open access: yesChemistry – A European Journal, EarlyView.
The introduction outlines the review scope. Microbial cell factories as living drugs cover host–gut microbiota, bacteria, yeast, and other microbial systems, with comparative host advantages. Engineering strategies include synthetic circuits, quorum sensing, and memory.
Cemile Elif Özçelik   +3 more
wiley   +1 more source

A pathophysiologic framework for the overlap of disorders of gut-brain interaction and the role of the gut microbiome

open access: yesGut Microbes
The International Rome Committee defines Disorders of Gut-Brain Interactions (DGBI) based upon distinct combinations of chronic and/or recurrent unexplained gastrointestinal symptoms. Yet patients often experience overlapping DGBI.
Ayesha Shah   +11 more
doaj   +1 more source

Associations Between Microbial Depletion and Autonomic Dysregulation in Binge‐Eating Disorder

open access: yesInternational Journal of Eating Disorders, EarlyView.
ABSTRACT Objective The interplay between the gut microbiome and autonomic nervous system remains unexplored in binge‐eating disorder (BED). We aimed to explore specific microbial alterations in BED and examine their potential association with cardiac vagal tone as a distinct bio‐behavioral phenotype.
Shuang Liang   +4 more
wiley   +1 more source

Gut microbiota therapy in gastrointestinal diseases

open access: yesFrontiers in Cell and Developmental Biology
The human gut microbiota, consisting of trillions of microorganisms, plays a crucial role in gastrointestinal (GI) health and disease. Dysbiosis, an imbalance in microbial composition, has been linked to a range of GI disorders, including inflammatory ...
Hanif Ullah   +11 more
doaj   +1 more source

Intermittent fasting with medium‐chain triglycerides in drug‐resistant epilepsy: A pilot crossover trial

open access: yesEpilepsia, EarlyView.
Abstract Objective Ketogenic dietary therapies can reduce seizure frequency in drug‐resistant epilepsy, but adherence to the classical ketogenic diet is often poor. Intermittent fasting supplemented with medium‐chain triglycerides (MCTs) may offer a more feasible and less restrictive alternative.
Wiebke Hahn   +11 more
wiley   +1 more source

Home - About - Disclaimer - Privacy